Gene Therapy Continues to Show Promise in Non-Hodgkin Lymphoma
The Annual Meeting of the American Society of Hematology (ASH), convened in December 2014, highlighted…
The Annual Meeting of the American Society of Hematology (ASH), convened in December 2014, highlighted…
Though much of the lymphoma research presented at the Annual Meeting of the American Society…
Double hit lymphoma (DHL) describes patients whose lymphoma tumors exhibit mutations on two significant genes,…
Among the many exciting clinical trials results presented at the Annual Meeting of the American…